This site is intended for health professionals only
Saturday 25 May 2019
Share |

Fungus drug "slows cancer growth"

A popular anti-fungal drug slows tumours in mice and should be investigated as a cheap way of fighting cancer in people, researchers have claimed.

While not wiping out the condition completely, itraconazole, marketed under the name Sporanox by Janssen Pharmaceutica, may boost the potency of other treatments by acting on a molecular pathway linked to the development of cancer.

Scientists at Stanford University looked at 2,400 different approved treatments that acted on the so-called Hedgehog pathway, finding that itraconazole was the least toxic.

The drug was then tested on mice, with the study finding that an oral form of the drug significantly slowed the growth of tumours injected under the skin.

Dr Philip Beachy, who worked on the study, claimed the treatment could soon be used on people.

He said: "It might be possible with two compounds to achieve a more potent block at even lower drug concentrations. If so, it's possible that there is a population of patients that can be treated relatively soon."

The results were published in the journal Cancer Cell.

Copyright Press Association 2010
Janssen Pharmaceutica

Ads by Google

You are leaving

You are currently leaving the Nursing in Practice site. Are you sure you want to proceed?


Respect for nurses: Sign up to our e-petition TODAY

The Nursing in Practice Respect campaign is now live! Over the coming months, we're set to highlight the vital contribution and efforts of primary care and community care nurses throughout the UK.

As part of our campaign, Nursing in Practice is looking to call on parliament to set up a debate to celebrate the vital work that you do.



Calling all primary care nurses! 'Like' our Nursing in Practice Facebook page to enter our free draw to win a £25 M&S voucher